A double-blind, placebo-controlled, 4-arm, Phase 2B study to asses the efficacy and safety of a 14-Day dosing regimen of 3 doses of ATB-346 versus Placebo, orally administered once daily to male and female patients diagnosed with Osteoarthritis of the Knee.